CD25 shedding by human natural occurring cd4+cd25+ regulatory T cells does not inhibit the action of IL-2

Scandinavian Journal of Immunology

Volumn 70, Issue 1, 2009, Pages 40-43

  Pedersen, A E ^a   Lauritsen, J P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; CD4 ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TUMOR IMMUNITY; CELL PROLIFERATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD4; CELL PROLIFERATION; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 67649801094     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02268.x     Document Type: Article

References (14)

1. Vignali DAA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008 8 : 523 32.
2. van Mierlo GJD, Scherer HU, Hameetman M et al. Cutting Edge: TNFR-shedding by CD currency sign +CD25+ regulatory T cells inhibits the induction of inflammatory mediators. J Immunol 2008 180 : 2747 51.
3. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998 188 : 287 96.
4. Pui CH, Ip SH, Iflah S et al. Serum interleukin-2 receptor levels in childhood acute lymphoblastic leukemia. Blood 1988 71 : 1135 7.
5. Mahida YRGA, Kulak L, Hawkey CJ. Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease. Clin Exp Immunol 1990 82 : 75 80. (Pubitemid 20329241)
6. Pizzolo G. The soluble interleukin-2 receptor as a new biological marker in diseases. Allergol Immunopathol 1991 19 : 176 80.
7. von Bergwelt-Baildon MS, Popov A, Saric T et al. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood 2006 108 : 228 37.
8. Takahashi T, kuniyasu Y, Toda M et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998 10 : 1969 80.
9. Collison LW, Workman CJ, Kuo TT et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007 450 : 566 9.
10. Joetham A, Takeda K, Taube C et al. Naturally occuring lung CD4+CD25+ T cell regulation of airway allergic responses depends on IL-10 induction of TGF-b. J Immunol 2007 178 : 1433 42.
11. hawrylowicz CM, P'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005 5 : 271 83.
12. Eicher DM, Waldmann TA. IL-2R alpha on one cell can present IL-2 to Il-2R beta/gamma(c) on another cell to augment IL-2 signalling. J Immunol 1998 161 : 5430 7.
13. Kronin V, Vremec D, Shortman K. Does the IL-2 receptor alpha chain induced on dendritic cells have a biological function. Int Immunol 1998 10 : 237 40.
14. Barthlott T, Moncrieffe H, Veldhoen M et al. CD25+CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production. Int Immunol 2005 17 : 279 88.